A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Completed

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to evaluate the comfort of BEPREVE compared to LASTACAFT after instillation.

Key facts

Study ID

NCT01339507

Run by

Cunningham, Derek N., O.D., P.A.

People needed

25

Starts

2011-04-01

Expected to finish

2011-06-01

Last updated by the study team

2016-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Each patient must meet the following criteria to be enrolled in this study:
• Are male or female at least 18 years of age who are diagnosed with allergic conjunctivitis.
• Have allergic ocular symptoms within the last three days.
• Are willing/able to follow instructions from the study investigator and his/her staff.
• Have signed informed consent approved by Institutional Review Board or Independent Ethics Committee.

You may not qualify if…

• Patients who meet any of the following criteria will be excluded from the study:
• Have known hypersensitivity to either BEPREVE™ or LASTACAFT® or to any component of the test article (including "procedural" medications such as anesthetic and/or fluorescein drops, dilating drops, etc.).
• Have active corneal pathology noted in the study eye at the screening visit. Active corneal pathology is defined as corneal pathology that is non stable, or greater than mild, or will compromise assessment of the safety or efficacy of treatment.
• Are pregnant or nursing/lactating.

Where it is running

• Derek Cunningham — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.